Previous close | 5.0000 |
Open | 2.7500 |
Bid | 0.0000 |
Ask | 4.5000 |
Strike | 290.00 |
Expiry date | 2025-01-17 |
Day's range | 2.7500 - 2.7500 |
Contract range | N/A |
Volume | |
Open interest | 192 |
Vertex stock advanced Tuesday as analysts debated the company's pain drug with one saying it could eventually generate $11.4 billion in sales.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call